GUGGENHEIM CAPITAL LLC - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 84 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$14,0000.0%25,0090.0%0.00%
Q1 2016$14,000
+40.0%
25,009
+121.4%
0.00%
Q4 2015$10,000
+11.1%
11,2980.0%0.00%
Q3 2015$9,000
-78.0%
11,298
-32.6%
0.00%
Q1 2015$41,0000.0%16,763
+3.1%
0.00%
Q4 2014$41,000
-70.5%
16,260
-23.7%
0.00%
Q2 2014$139,000
-10.3%
21,301
-8.8%
0.00%
Q1 2014$155,000
+84.5%
23,350
+32.5%
0.00%
Q4 2013$84,000
+10.5%
17,624
+15.5%
0.00%
Q3 2013$76,000
-6.2%
15,254
-1.2%
0.00%
Q2 2013$81,00015,4430.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 3,500,000$8,576,0001.54%
GREAT POINT PARTNERS LLC 1,038,652$2,545,0001.12%
BVF INC/IL 1,893,030$4,638,0000.97%
Healthcare Value Capital, LLC 200,000$490,0000.53%
Healthcare Value Capital, LLC 200,000$490,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 1,300,000$3,185,0000.33%
DSC Advisors, L.P. 225,000$551,0000.29%
Perceptive Advisors 700,000$1,715,0000.13%
DSC Advisors, L.P. 400,000$240,0000.13%
Endurant Capital Management LP 140,000$343,0000.11%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders